ABSTRACT
Recent resting-state fMRI studies in stroke patients have identified two robust biomarkers of acute brain dysfunction: a reduction of inter-hemispheric functional connectivity (FC) between homotopic regions of the same network, and an abnormal increase of ipsilesional FC between task-negative and task-positive resting-state networks (RSNs). Whole-brain computational modeling studies, at the individual subject level, using undirected effective connectivity (EC) derived from empirically measured FC, have shown a reduction of measures of integration and segregation in stroke as compared to healthy brains. Here we employ a novel method, first, to infer whole-brain directional EC from zero-lagged and lagged FC, then, to compare it to empirically measured FC for predicting stroke vs. healthy status, and patient performance (zero, one, multiple deficits) across neuropsychological tests. We also investigated the accuracy of FC vs. model EC in predicting the long-term outcome from acute measures.
Both FC and EC predicted healthy from stroke individuals significantly better than the chance-level, however, EC accuracy was significantly higher than that of FC at 1-2 weeks, three months, and one year post-stroke. The predictive FC links mainly included those reported in previous studies (within-network inter-hemispheric, and between task-positive and -negative networks intra-hemispherically). Predictive EC links included additional between-network links. EC was a better predictor than FC of the number of behavioral domains in which patients suffered deficits, both at two weeks and one-year post onset of stroke. Interestingly, patient deficits at one-year time point were better predicted by EC values at two weeks rather than at one-year time point. Our results thus demonstrate that the second-order statistics of fMRI resting-state activity at an early stage of stroke, derived from a whole-brain EC, estimated in a model fitted to reproduce the propagation of BOLD activity, has pertinent information for clinical prognosis.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding was provided by NIH grant R01 NS095741 to M.C.; M.G. was supported by Horizon 2020 Framework Programme, Award ID: Human Brain Project SGA2 No. 785907.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Study procedures were performed in accordance with the Declaration of Helsinki ethical principles and approved by the Institutional Review Board at Washington University in St. Louis. The complete data collection protocol is described in full detail in a previous publication (Corbetta et al., Neuron, 2015).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The full set of neuroimaging and behavioral data are available at http://cnda.wustl.edu/app/template/Login.vm. Specific data and analysis scripts are available on request to the authors.
